Evidence map›Paper›PMID 29075924›Full record

ArticleJournal of thrombosis and thrombolysis2018

Contemporary use of P2Y

Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, Krzysztof Plens, Paweł Kleczyński, Dariusz Dudek

Abstract readMulticenter Study
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Antiplatelets in acute coronary syndrome in Poland - from guidelines to clinical practice.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2021
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomasz Rakowski2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501, Krakow, Poland. mcrakows@cyfronet.pl.ORCID http://orcid.org/0000-0001-6478-6186
Zbigniew SiudakDepartment of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Artur Dziewierz2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501, Krakow, Poland.
Krzysztof PlensKCRI, Krakow, Poland.
Paweł Kleczyński2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501, Krakow, Poland.
Dariusz DudekDepartment of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to guidelines, it is recommended to give P2Y

Indexed as

Receptors, Purinergic P2Y12AdenosineAdultAgedClopidogrelHumansMiddle AgedPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPolandPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsRegistriesST Elevation Myocardial InfarctionTicagrelorTiclopidineAdenosineClopidogrelPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsReceptors, Purinergic P2Y12TicagrelorTiclopidineAntiplatelet therapyMyocardial infarctionPrimary PCIRegistries

Identifiers

PMID29075924
PMCPMC5756271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.